戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 iated with both mast cell- and IgE-dependent passive cutaneous anaphylaxis (except at sites engrafted
2 luence IgE-mediated mast cell activation and passive cutaneous anaphylaxis (PCA) in vivo.
3 es or IgE-dependent mast cell activation and passive cutaneous anaphylaxis (PCA) in vivo.
4 n of MC functions in vivo was studied in the passive cutaneous anaphylaxis (PCA) MC-dependent model.
5 4-3-3zeta function in a MC-dependent in vivo passive cutaneous anaphylaxis (PCA) model of allergic in
6 n (OVA) percutaneous sensitized AD model and passive cutaneous anaphylaxis (PCA) model on VAD and vit
7 endent responses using a mast cell-dependent passive cutaneous anaphylaxis (PCA) model, as well as in
8 nzyme-linked immunosorbent assay (ELISA) and passive cutaneous anaphylaxis (PCA).
9 ing via immunochemistry and a mouse model of passive cutaneous anaphylaxis (PCA).
10                                       Murine passive cutaneous anaphylaxis after sensitization with p
11 t with our in vitro data, mast cell-mediated passive cutaneous anaphylaxis and passive systemic anaph
12 rgic actions of artesunate were evaluated in passive cutaneous anaphylaxis and passive systemic anaph
13 mast cell biology and a preclinical model of passive cutaneous anaphylaxis and passive systemic anaph
14 rpermeability, prevented vascular leakage in passive cutaneous anaphylaxis and protected from systemi
15 antly increased sensitivity to IgE-dependent passive cutaneous anaphylaxis as assessed by greater tis
16 T(1)R-deficient mice undergoing IgE-mediated passive cutaneous anaphylaxis as compared with the wild-
17 pression of IgE-mediated mast cell-dependent passive cutaneous anaphylaxis but can enhance the tissue
18                                         In a passive cutaneous anaphylaxis experiment, W(sh)/W(sh) ma
19 e WPE-induced, peanut-specific, IgE-mediated passive cutaneous anaphylaxis in hFcepsilonRIalpha trans
20 lity to respond to Ag in vivo as measured by passive cutaneous anaphylaxis in mice after irradiation.
21 isruptive IgE inhibitors efficiently prevent passive cutaneous anaphylaxis in mice expressing the hum
22 he functional blocking ability of mAbs using passive cutaneous anaphylaxis in mice with humanized Fce
23 d that RDE (II)-treated IgE could not induce passive cutaneous anaphylaxis in mouse ears.
24                Moreover, IgE-dependent local passive cutaneous anaphylaxis in response to challenge w
25 y and the absence of IgE/mast cell-dependent passive cutaneous anaphylaxis in the ear and joint as we
26 ation of plasma protein and the IgE-mediated passive cutaneous anaphylaxis in the ear were significan
27 rophenylacetyl) and anti-dansyl IgE-mediated passive cutaneous anaphylaxis in transgenic mice express
28 when tested for IgE- and mast cell-dependent passive cutaneous anaphylaxis in vivo or IgE-dependent m
29  gene deletion prevents vascular leakage and passive cutaneous anaphylaxis in vivo, and ROCK inhibito
30  by beta-hexosaminidase release in vitro and passive cutaneous anaphylaxis in vivo.
31 oral HMO treatment were also measured in the passive cutaneous anaphylaxis model, and direct effects
32 brutinib inhibited mast cell activation in a passive cutaneous anaphylaxis model.
33  basophilic leukemia mast cell model, in the passive cutaneous anaphylaxis mouse model of allergy, an
34  via blocking ELISA, flow cytometry, and the passive cutaneous anaphylaxis mouse model.
35 tected from vascular edema induced by either passive cutaneous anaphylaxis or direct challenge with h
36 ant animal conferred an abnormally decreased passive cutaneous anaphylaxis reaction on mast cell-defi
37 n complexes in their secretory granules, the passive cutaneous anaphylaxis reaction was induced in th
38  In addition, we found significantly reduced passive cutaneous anaphylaxis reactions in gal3(-/-) mic
39 osyllactose and 6'-sialyllactose reduced the passive cutaneous anaphylaxis response, but only 6'-sial
40 ions resulted in the development of a robust passive cutaneous anaphylaxis response.
41 degranulation in vivo as measured by reduced passive cutaneous anaphylaxis responses.
42                                          The passive cutaneous anaphylaxis showed that peanut-specifi
43 sophil histamine release assay and the human passive cutaneous anaphylaxis test were utilized to stud
44  alpha-chain transgenic mice in a functional passive cutaneous anaphylaxis test.
45 nous LTC4 and to endogenous CysLTs evoked by passive cutaneous anaphylaxis was augmented in TG mice.
46                  In these mice, IgE-mediated passive cutaneous anaphylaxis was largely abolished.
47 r permeability associated with IgE-dependent passive cutaneous anaphylaxis was significantly reduced
48                           A hapten model and passive cutaneous anaphylaxis were used to characterize
49 in inflammation (histamine- and IgE-mediated passive cutaneous anaphylaxis) we topically applied fing
50 lls, suppressed peanut-specific IgE-mediated passive cutaneous anaphylaxis, and attenuated dansyl IgE
51 s, impaired gastric acid secretion, impaired passive cutaneous anaphylaxis, and decreased mast cell d
52  to be responsible for FcgammaRIIA-dependent passive cutaneous anaphylaxis, and monocytes/macrophages
53                             In IgE-dependent passive cutaneous anaphylaxis, GPR17-deficient mice show
54 em were contrasted with data generated using passive cutaneous anaphylaxis, ovalbumin-induced asthma
55        Heat-inactivated immune serum induced passive cutaneous anaphylaxis, suggesting that anaphylax
56 late phase inflammation in a murine model of passive cutaneous anaphylaxis.
57 nse in SphK2-null mice challenged to undergo passive cutaneous anaphylaxis.
58 deficient mice display impaired IgE-mediated passive cutaneous anaphylaxis.
59  stronger acute response in a mouse model of passive cutaneous anaphylaxis.
60 nut-, cat-, and dansyl-specific IgE-mediated passive cutaneous anaphylaxis; and attenuate dansyl IgE-
61      Accordingly, allergic reactions such as passive cutaneous and systemic anaphylaxis are markedly
62                                 In contrast, passive cutaneous warming and body core warming showed c